EV/EBITDA
-12.90
+1.57+10.85%
Thu, 27 Feb 2025 22:50:12 GMT
Summary
- As of February 28, 2025, CTOR EV/EBITDA is -12.90, with a rise of +1.57 (+10.85%) during the most recent trading day.
- CTOR EV/EBITDA is now -18.57% below its all-time high of -10.88.
Performance
CTOR EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CTOR EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +10.8% | -10.8% | -11.3% |
| 1 m1 month | +8.0% | -8.0% | -8.3% |
| 3 m3 months | - | - | +17.0% |
| 6 m6 months | - | - | -32.1% |
| ytdytd | +4.2% | -4.2% | -4.3% |
| 1 y1 year | - | - | -90.0% |
| 5 y5 years | - | - | - |
CTOR EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -15.03 | +14.2% | |
| 3 m | 3-month | -10.88 | -18.6% | -18.72 | +31.1% |
| 6 m | 6-month | -10.88 | -18.6% | -18.72 | +31.1% |
| 1 y | 1-year | -10.88 | -18.6% | -18.72 | +31.1% |
| 3 y | 3-year | -10.88 | -18.6% | -18.72 | +31.1% |
| 5 y | 5-year | -10.88 | -18.6% | -18.72 | +31.1% |
| alltime | all time | -10.88 | -18.6% | -18.72 | +31.1% |
Citius Oncology EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -12.90(-4.2%) |
| Date | Value |
|---|---|
| 2024 | -13.46 |
FAQ
- What is Citius Oncology EV/EBITDA?
- What is the all time high EV/EBITDA for Citius Oncology?
- What is CTOR EV/EBITDA year-to-date change?
What is Citius Oncology EV/EBITDA?
The current EV/EBITDA of CTOR is -12.90
What is the all time high EV/EBITDA for Citius Oncology?
Citius Oncology all-time high EV/EBITDA is -10.88
What is CTOR EV/EBITDA year-to-date change?
Citius Oncology EV/EBITDA has changed by +0.56 (+4.16%) since the beginning of the year